A new British study has found that Pfizer COVID-19 vaccine is more effective if the second dose is delayed to 12-weeks after the first. The study, which has not yet been peer reviewed—found that delaying the second dose to 12 weeks led to an antibody response that was three-and-half times larger than when vaccine doses were kept to the standard recommendation of three weeks apart

Study: Pfizer COVID-19 vaccine doses more effective with a 12-week gap

study-on-pfizer-vaccine

Study On Pfizer Vaccine, News on Study On Pfizer Vaccine, stories on Study On Pfizer Vaccine, articles on Study On Pfizer Vaccine, Study On Pfizer Vaccine stories at Wion, Study On Pfizer Vaccine news, Study On Pfizer Vaccine latest news

study on-pfizer-vaccine

Study: Pfizer COVID-19 vaccine doses more effective with a 12-week gap